Me. Ripps et al., TRANSGENIC MICE EXPRESSING AN ALTERED MURINE SUPEROXIDE-DISMUTASE GENE PROVIDE AN ANIMAL-MODEL OF AMYOTROPHIC-LATERAL-SCLEROSIS, Proceedings of the National Academy of Sciences of the United Statesof America, 92(3), 1995, pp. 689-693
Amyotrophic lateral sclerosis is a progressive neurodegenerative disor
der primarily involving motoneurons. A subset of individuals with fami
lial autosomal dominant forms of the disease have mutations of the cop
per/zinc superoxide dismutase (Cu/Zn SOD, SOD-1) gene, which encodes a
ubiquitously expressed enzyme that plays a key role in oxygen free ra
dical scavenging. This observation suggests that altered or reduced SO
D-1 activity may play a role in the neurodegenerative process. To expl
ore this possibility further, we have introduced a mutation into the m
ouse SOD-1 gene that corresponds to one of the changes found in the hu
man gene in familial amyotrophic lateral sclerosis. Integration and ex
pression of this mouse gene in transgenic mice was identified by the p
resence of a unique restriction enzyme site in the transgene coding se
quence generated by introduction of the mutation. We report here that
high expression of this altered gene in the central nervous systems of
transgenic mice is associated with an age-related rapidly progressive
decline of motor function accompanied by degenerative changes of moto
neurons within the spinal cord, brain stem, and neocortex. These findi
ngs indicate a causative relationship between altered SOD activity and
motoneuron degeneration. Moreover, biochemical studies indicate norma
l levels of total SOD activity in transgenic mouse tissues, results th
at indicate that the neurodegenerative disorder does not result from a
diminution of activity and, as such, represents a dominant ''gain of
function'' mutation.